How to manage diabetic ketoacidosis step by step? | Rounds How to manage diabetic ketoacidosis step by step? | Rounds
Loading...

How to manage diabetic ketoacidosis step by step?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 · View editorial policy

Diabetic Ketoacidosis (DKA) Initial Management (Step-by-Step)

DKA management should proceed with prompt treatment of dehydration, insulin deficiency, ketoacidosis, and electrolyte deficits, plus identification and treatment of the precipitating cause [1].
The standard immediate priorities are IV fluids, IV insulin, and potassium-directed electrolyte replacement with frequent laboratory reassessment [1].

Diagnostic Confirmation and Treatment Priorities

DKA diagnosis requires diabetes or hyperglycemia (glucose ≥200 mg/dL or prior diabetes), ketosis (beta-hydroxybutyrate ≥3.0 mmol/L or urine ketones ≥2+), and metabolic acidosis (pH <7.3, bicarbonate <18 mmol/L, or both) Hyperglycemic Crises 2024 Consensus Report.
Initial management should also address competing life threats such as shock, sepsis, acute coronary syndrome, and severe electrolyte abnormalities Hyperglycemic Crises 2024 Consensus Report.

Immediate Orders and Monitoring

IV access should be established and intensive monitoring should be initiated, including serial serum electrolytes and acid–base assessment [1].
Continuous cardiac monitoring should be used for severe electrolyte derangements, especially when potassium abnormalities are present or expected JBDS 02 DKA in Adults (March 2023).
Fluid balance tracking and urine output surveillance should be implemented JBDS 02 DKA in Adults (March 2023).

Step 1: IV Fluid Resuscitation

Isotonic crystalloid should be started promptly for volume depletion [1].
Fluid replacement should target restoration of circulating volume with approximately 50% of the estimated fluid deficit replaced in the first 8–12 hours [2].
Smaller boluses should be considered in older adults and in patients at high risk for fluid overload, including those with heart or kidney failure [3].

Step 2: Potassium-Directed Electrolyte Replacement Before Insulin

Potassium should be replaced early in DKA with frequent monitoring for hypokalemia [4].
If serum potassium is <3.5 mmol/L at presentation, insulin therapy should be postponed and potassium replacement should be initiated first to reduce the risk of lethal arrhythmias and respiratory muscle weakness Hyperglycemic Crises 2024 Consensus Report.
When potassium is <3.5 mmol/L, potassium replacement is recommended at 10 mmol per hour until potassium is above 3.5 mmol/L [3].
DKA patients typically have a large total-body potassium deficit, and insulin therapy increases potassium entry into cells, so ongoing potassium supplementation is usually required during insulin infusion [2].

Step 3: Initiate IV Insulin and Adjust to Glucose

IV regular insulin should be initiated after initial volume resuscitation and after safe potassium is confirmed [1].
Intravenous insulin infusion should be adjusted to maintain plasma glucose around 200 mg/dL (11.1 mmol/L) Hyperglycemic Crises 2024 Consensus Report.
When plasma glucose falls to approximately 10–15 mmol/L (180–270 mg/dL), glucose-containing fluids should be started to allow continued insulin infusion for ketone clearance [4].

Step 4: Metabolic Acidosis (Bicarbonate) Use

Bicarbonate is not routinely required because insulin and fluids usually correct metabolic acidosis by resolving ketoacidosis [5].

Step 5: Treat the Precipitating Cause

A precipitating cause should be sought immediately, including infection, missed insulin, pump failure, myocardial ischemia, or other acute stressors [1].
Targeted treatment should be started concurrently with DKA correction Hyperglycemic Crises 2024 Consensus Report.

Step 6: Continue Until Ketosis Resolution and Transition Planning

Insulin infusion should continue until ketoacidosis resolves, defined by clinical improvement and normalization of acid–base status with resolution of ketonemia/ketonuria Hyperglycemic Crises 2024 Consensus Report.
Transition to subcutaneous insulin should include an overlap period between IV insulin discontinuation and first subcutaneous rapid-acting insulin to prevent rebound hyperglycemia or recurrent ketoacidosis [6] and JBDS 02 DKA in Adults (March 2023).

Targets and Stopping Criteria

Glucose should be maintained near 200 mg/dL (11.1 mmol/L) during insulin infusion to safely clear ketones Hyperglycemic Crises 2024 Consensus Report.
DKA treatment should continue until ketoacidosis resolves, with ongoing monitoring of acid–base status and ketosis [1].
The anion gap should not be used alone as a criterion to stop therapy because hyperchloremic acidosis from large-volume saline can make it misleading [6].

Related Questions